scispace - formally typeset
E

Erik J. Suuronen

Researcher at University of Ottawa

Publications -  135
Citations -  5490

Erik J. Suuronen is an academic researcher from University of Ottawa. The author has contributed to research in topics: Progenitor cell & Cell therapy. The author has an hindex of 39, co-authored 130 publications receiving 4500 citations.

Papers
More filters
Journal ArticleDOI

Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention

TL;DR: A brief overview of concepts of bacterial biofilm formation, current state-of-the-art therapeutic approaches for preventing and treating biofilms, and the prevalence of such infections on medical devices is reviewed.
Journal ArticleDOI

Click hydrogels, microgels and nanogels: Emerging platforms for drug delivery and tissue engineering

TL;DR: Recent exciting developments in click hydrogels, microgels and nanogels, as well as their biomedical applications such as controlled protein and drug release, tissue engineering, and regenerative medicine are presented and discussed.
Journal ArticleDOI

Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold

TL;DR: Cell-free implants, comprising carbodiimide crosslinked recombinant human collagen (RHC) can achieve stable regeneration and therefore, represent a potentially safe alternative to donor organ transplantation.
Journal ArticleDOI

Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation

TL;DR: An implantable matrix is reported that performs as a physiologically functional tissue substitute and not simply as a prosthetic device, which should have applicability to many areas of tissue engineering and regenerative medicine, especially where nerve function is required.
Journal ArticleDOI

Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood.

TL;DR: This work demonstrates a novel approach for the expansion and delivery of blood CD133+ cells with resultant improvement of their implantation and vasculogenic capacity and significantly improved the restoration of a vascular network.